Intec, a clinical-stage biotech that develops drugs based on its proprietary Accordion Pill platform technology, said top-line data from a pivotal Phase 3 trial dubbed ACCORDANCE did not achieve the ...

Intec Pharma, maker of the Accordian Pill delivery platform, secured a $5.2 million grant from the Israeli government to support late-stage R&D for its Parkinson’s candidate, which makes use of the ...

JERUSALEM, March 15, 2021 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") announced today that it has entered into a definitive agreement for a business combination with ...

Intec Pharma’s Parkinson’s gradual release disease drug trial has missed its primary endpoint, causing the biotech’s share price to crash. Shares in the US biotech fell from an opening price of $3.43 ...

SAN DIEGO, CA / ACCESSWIRE / June 26, 2023 / IKIN™, a leading provider of visual technology solutions for businesses and consumers, announced it has signed a product development agreement with INTEC I ...

What's Intec Capital Ltd share price today. Get Intec Capital Ltd latest news on BSE/NSE stock price live updates, Intec Capital Ltd financial results and overview, Intec Capital Ltd stock price ...